JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hahnenkamp, K.
Right arrow Articles by Hoenemann, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hahnenkamp, K.
Right arrow Articles by Hoenemann, C. W.
Related Collections
Right arrow Cardiovascular
Right arrow Trauma
Right arrow Pharmacology

Anesth Analg 2002;94:1441-1447
© 2002 International Anesthesia Research Society

CARDIOVASCULAR ANESTHESIA

The Effects of Local Anesthetics on Perioperative Coagulation, Inflammation, and Microcirculation

Klaus Hahnenkamp, MD, Gregor Theilmeier, MD, Hugo K. Van Aken, PhD, and Christian W. Hoenemann, MD

Department of Anesthesiology and Intensive Care Medicine, University Hospital Muenster, Muenster, Germany

Address correspondence and reprint requests to Hugo Van Aken, PhD, Department of Anesthesiology and Intensive Care Medicine, University Hospital Muenster, Albert-Schweitzer-Str. 33, 48129 Muenster, Germany. Address e-mail to hva{at}uni-muenster.de


   Introduction
Top
 Introduction
Stress Response
 Coagulation Factors and...
 Platelet Aggregation
 Inflammatory Response
 Microcirculation
 Conclusion
 References
 
Major surgery is associated with a hypercoagulable and proinflammatory state that persists into the postoperative period (1,2). Perioperative inflammatory responses to trauma can trigger hypercoagulability, especially in patients undergoing vascular surgery, and are associated with vasoocclusive and thromboembolic events—major causes of postoperative morbidity and mortality (3–5). The mechanisms for these effects are poorly understood, but hypercoagulability seems to originate from what is known as the "stress response" to major surgery (4,6).

Postoperative changes occur in all aspects of the coagulation system, including increased plasma levels of coagulation factors (1), decreased levels and more rapid inactivation of endogenous coagulation inhibitors (7), enhanced platelet reactivity (8), and impaired fibrinolysis (9). In addition, increasing attention has been given to the close link between hemostasis and inflammation (10), which is minutely influenced by general anesthesia with parenteral opioids (3).

However, recent evidence suggests that regional anesthesia has a protective effect against the perioperative stress response. The beneficial effects of the epidural administration of local anesthetic (LA) have been attributed to the changes in physiology induced by neuraxial anesthesia and better pain management (5,11). However, as discussed below, there are hints that the pharmacodynamic effects of LA itself may contribute to these effects.

This review is arranged according to the different effects of LAs—first on the hypercoagulable and inflammatory responses to surgery, and second on microcirculation.


   Stress Response
Top
 Introduction
 Stress Response
Coagulation Factors and...
 Platelet Aggregation
 Inflammatory Response
 Microcirculation
 Conclusion
 References
 
Surgical trauma and stress generate a status that is characterized by vasodilation, increased vascular permeability (inflammation), and sensitization of nociceptors (primary pain) (12). This is a result of a local release of multiple chemical substances, e.g., substance P, bradykinin, serotonin, and prostaglandins (PgE) from a cascade of arachidonic acid metabolites from afferent nerve endings (Fig. 1) (12). In addition to the local response and transmitter release, surgical stress stimulates sympathetic division of the autonomic nervous system. Postganglionic fibers of the sympathetic nervous system secrete norepinephrine as the neurotransmitter. These norepinephrine-secreting neurons are classified as adrenergic fibers. Responses evoked by autonomic sympathetic nervous system stimulation are shown in Table 1. Both responses to surgical stress—the release of neuroendocrinic hormones and the local release of transmitters—are important for the subsequent course of healing and postoperative outcome.



View larger version (26K):
[in this window]
[in a new window]
  		Figure 1. Local response to surgical trauma. Surgical trauma and stress result in a local release of multiple chemical substances, e.g., substance P (sP), bradykinin (BK), serotonin (5-HT), and prostaglandins (PgE) from a cascade of arachidonic acid metabolites from afferent nerve endings. HPETE = hydroperoxy-eicosatetraenoic acid. Modified from Ref. 12.

 

View this table:
[in this window]
[in a new window]
  		Table 1. Responses Evoked by Autonomic Sympathetic and Parasympathetic Nervous System Stimulation
 
Perioperative pain control using regional anesthesia techniques may be a powerful tool for reducing perioperative stress (13). Reduced incidences of vascular graft occlusion and thromboembolic complications have been demonstrated, along with decreased perioperative coagulability, when epidural anesthesia and analgesia were compared with general anesthesia (5,14–16). Serum markers that may reflect the humoral stress response (i.e., catecholamines, corticotropin, thromboxane A2 [TXA2], and antidiuretic hormone) are decreased by epidural blockade (17–19), but not by general anesthesia (20). Most authors have interpreted the better effectiveness of postoperative pain management with epidural anesthesia as being the underlying reason for the diminished stress response (5,11) compared with intermittent on-demand opioid analgesia. However, stress-mediated increases in serum variables, such as angiotensin (secondary to a more intense renin activity), catecholamines, and TXA2, activate platelets (21,22) and can be prevented by regional anesthesia. A reduction in the stress response with epidural anesthesia and analgesia may therefore indirectly affect platelet aggregation (20). In addition to this indirect effect, LAs directly influence some of the receptors and their signaling pathways [i.e., PgE2 (EP1) (23), TXA2 (24), and lysophosphatidic acid (25)] that are involved in inflammatory processes, platelet activation, nociception, and peripheral pain. A pronounced inhibition of these receptors by LAs in plasma, absorbed from the epidural space, has been demonstrated, and this has been confirmed in other studies and in several experimental models (26,27). The exact mechanisms are unclear, but one effect is at the G protein, for receptors coupled to G{alpha}(q) proteins (28). Other potential mechanisms are possible, e.g., a reduced variables release or direct LA effects on proteins, or within their signaling cascades.


   Coagulation Factors and Fibrinolysis
Top
 Introduction
 Stress Response
 Coagulation Factors and...
Platelet Aggregation
 Inflammatory Response
 Microcirculation
 Conclusion
 References
 
Several studies have shown that epidural anesthesia reduces the incidence of thrombotic events (14,15) and is associated with beneficial effects on postoperative outcome (5). These effects are accompanied by a decrease in intraoperative blood loss (14,15), and may be attributed either to physiologic changes induced by neuraxial anesthesia or to pharmacologic effects of LA on the coagulation system. Some putative direct effects of epidurally administered LA on coagulation and fibrinolysis variables have been investigated by determining parts of the coagulatory and fibrinolytic pathway activity. The perioperative increases of factor VIII and von Willebrand factor—the latter mediating attachment of platelets to the vascular wall—could in part contribute to perioperative thrombosis (29). Bredbacka et al. (30) reported less pronounced releases of factor VIII and von Willebrand factor with epidural anesthesia compared with general anesthesia in patients undergoing abdominal hysterectomy, whereas factors II and X remained unchanged in a study by Henny et al. (31). Variables for estimating fibrinolytic activity were measured in the blood of patients undergoing elective lower extremity vascular reconstruction. These studies demonstrated, first, that epidural anesthesia enhances fibrinolytic activity by preventing the postoperative release of plasminogen activator inhibitor-1 protein (4); second, a larger baseline concentration of plasminogen activators; and third, an increased capacity of the venous endothelium to release plasminogen activators (14). In addition, antithrombin III, the principal inhibitor of thrombin activity, which progressively decreases during the early postoperative period (29), returns to preoperative concentrations more rapidly in patients receiving epidural LA (2).

All of these studies suggest that the epidural administration of LA is able to reverse, or at least limit, perioperative hypercoagulability by preventing the release of procoagulatory mediators, by inhibiting their signaling pathways, or through increased fibrinolysis.


   Platelet Aggregation
Top
 Introduction
 Stress Response
 Coagulation Factors and...
 Platelet Aggregation
Inflammatory Response
 Microcirculation
 Conclusion
 References
 
Platelet aggregation is one of the most important steps in hemostasis. Several studies published in the 1980s demonstrated an inhibitory effect of epidurally administered LAs on platelet aggregation (14,31,32). In a study conducted by Hollmann et al. (33), a new device (Clot Signature Analyzer®; Xylum Corp., Scarsdale, NY) was used to evaluate perioperative hypercoagulation. Clot signature analysis is a novel technique for determining interactions between platelets, proteins, and collagen surfaces. It provides a simulated vascular flow environment for assessing both the platelet and coagulation activities of native whole blood. In this study, the use of epidural anesthesia prevented immediate postoperative hypercoagulability, without affecting physiologic aggregation and coagulation processes. However, there is evidence that LA per se affects aggregation.

The effect of the epidural administration of bupivacaine on platelet aggregation was studied by Odoom et al. (32) using adenosine diphosphate-induced platelet aggregation in platelet rich plasma in seven patients undergoing endoscopic transurethral prostate resection. The time of incubation of the LA after epidural administration seemed to have a major role, because a time lag of 1 h between the peak plasma concentration and the maximum platelet aggregation was striking. This might explain why, in a study published by Borg and Modig (34), 25-fold larger bupivacaine concentrations in platelet rich plasma were necessary to inhibit platelet aggregation after an incubation period of only 5 min. Odoom et al. (32) considered bupivacaine accumulation within the platelets as an explanation for the time lag.

This has been demonstrated by Weksler et al. (35) for propanolol, a ß-blocker with LA properties and comparable pharmacologic behavior. In 1977, the authors reported that propanolol inhibited platelet aggregation induced by adenosine diphosphate, epinephrine, collagen, thrombin, and the ionophore A23187. They also showed that platelets accumulated 14C-propanolol in vitro10- to 30-fold over plasma concentrations. Propanolol has an LA or membrane-stabilizing effect (36). The concentrations of propanolol needed for a membrane effect are larger (10-6–10-4 M) than for ß-adrenergic blockade (10-9–10-8 M). Also, the membrane-stabilizing effect is not stereospecific, unlike ß-blockade. Thus, D(+) and L(-) propanolol have similar membrane effects, whereas the D(+) isomer has only 1% of the ß-blockading capacity of the L(-) isomer. The concentration of propanolol required to inhibit platelet function in vitro(10-7–10-4 M) is large, suggesting a membrane effect. The conclusion inferred by these authors is supported by their finding that the D(+) and L(-) forms are equipotent inhibitors of platelet aggregation, serotonin release, and platelet adhesion to collagen. Furthermore, they showed that practolol, a potent ß-adrenergic blocking drug that lacks membrane stabilizing activity, has no effect on platelet function. Thus, the authors concluded that the membrane effect, and not ß-adrenergic blockade, seems to be crucial for the action of propanolol on platelets (35).

A significant correlation was observed among bupivacaine plasma levels, bupivacaine incubation time, and the inhibition of all platelet aggregation variables, which suggests that this effect is caused by the LA itself (32). A 1977 report by Cooke et al. (37) supports this view; they found that an IV application of a lidocaine bolus followed by continuous infusion for 6 postoperative days (leading to plasma concentrations of 4 x 10-6 to 2 x 10-5 M) reduced the risk for deep vein thrombosis (DVT) without increasing bleeding risks in patients undergoing elective hip surgery. Notably, after discontinuation of lidocaine (between postoperative days 7 and 14), 41% of these patients without thrombosis during therapy developed deep vein thrombosis. No differences were found between the groups with regard to blood loss or transfusion requirements. Thus, lidocaine seems to reduce the risk for thrombosis without increasing bleeding, and this effect shown in the study by Cooke et al. (37) must be attributable to a direct effect of the LA rather than to the effects of neuraxial block produced by epidural anesthesia.

Cytosolic mobilization of calcium from intracellular and extracellular sites is one of the earliest events in the activation process of platelets (38). There is evidence that LA blocks the Ca2+ uptake in platelets (39), as well as the influx of extracellular calcium, through selective inhibition of the Ca2+-dependent adenosine triphosphatase (40). An alternative hypothesis highlights the role of coagulation-associated pathways such as TXA2 signaling. TXA2 is a potent stimulator of platelet aggregation (41,42), and is one of the major mediators released during surgery (43,44). Kohrs et al. (27) studied the effects of bupivacaine (1–10 µM) on whole blood coagulation measured by using coagulation analysis and activated clotting time. Bupivacaine, in clinically relevant concentrations of 1–2 µM, influenced whole blood clotting characteristics. Thromboxane receptor antagonism increased activated clotting time in this study, confirming a role for thromboxane in coagulation. Bupivacaine inhibited TXA2 signaling, but seemed to block additional factors as well. Depolarization (45), changes in membrane microviscosity (46), and an increase in sodium uptake (47), are additional stimulatory factors during early platelet aggregation. Whether LA might influence these stimulatory factors of platelet aggregation has not been studied.


   Inflammatory Response
Top
 Introduction
 Stress Response
 Coagulation Factors and...
 Platelet Aggregation
 Inflammatory Response
Microcirculation
 Conclusion
 References
 
Surgical trauma is associated with the activation of inflammatory pathways. Depending on the procedure and the occurrence of any complications, this may lead to a generalized systemic inflammatory response syndrome. Links between inflammation and coagulation are emerging in several areas such as the cellular and protein levels.

At the cellular level, leukocytes bind tissue factor and other coagulation factors/complexes to their membranes, and through this mechanism activate the plasmatic coagulation cascade (48). Leukocytes are actively and specifically recruited to platelet clots (49). Platelets can cover leukocytes and thereby facilitate the adhesion of leukocytes to endothelium, diapedesis into the tissue, and release of inflammatory mediators. These are key events in the inflammatory response (50).

At the protein level, coagulation factors, such as tissue factor, its endogenous inhibitor protein tissue factor pathway inhibitor, and factor Xa, are increasingly accepted as inflammatory proteins (51). There is no doubt that the plasminogen activator urokinase has a major role in tissue remodeling after inflammatory or ischemic insults (52). Although the clinical benefits solely related to the antiinflammatory effects of LAs have not been demonstrated, there is growing evidence from in vitroand animal studies that supports the view that LAs can modulate these events. Lidocaine reduces leukocyte adherence and delivery to inflamed tissues (53). Ropivacaine very potently reduces rolling and adhesion of leukocytes to the inflamed vessel wall, as assessed by intravital microscopy (54). Lidocaine and tetracaine reduce superoxide release from polymorphonuclear neutrophils in vitro(55). Polymorphonuclear neutrophils from cardiac patients who had received lidocaine perioperatively as an antiarrhythmic therapy, reduced superoxide production to 20% (56). LAs inhibit the phagocytic activity of leukocytes (57). These antiinflammatory effects are in part explained by an inhibition of leukocyte priming (55), an activation step that determines the amplitude of the response to activation (58).

Some mechanisms of these antiinflammatory effects have been identified (59), going beyond changes in the ionic configuration of the plasma membrane, and some are still awaiting more detailed elucidation. One study showed an inhibition of PGE2 EP1 membrane receptors by bupivacaine (23), a receptor that is particularly relevant in inflammation and peripheral pain. Other receptors involved in inflammation and pain are affected by LAs. The lysophosphatidic acid receptor, which is involved in platelet aggregation, inflammation, and wound healing (25,60), and the thromboxane receptor (24,61), are inhibited. All of this evidence suggests direct effects of LAs on G protein-coupled receptors. One site of action of LAs within the G protein-coupled receptor pathway seems to be at the G{alpha}(q) protein (28), but there is increasing evidence indicating more than one mechanism of action of LAs. Butterworth et al. (62) demonstrated LA inhibition of ß2-adrenergic receptor binding at micromole concentration. LAs affect ion channels, e.g., sodium channels (63) and G protein-activated K+ channels (64).


   Microcirculation
Top
 Introduction
 Stress Response
 Coagulation Factors and...
 Platelet Aggregation
 Inflammatory Response
 Microcirculation
Conclusion
 References
 
Although controversial, the incidence of thrombosis of vascular grafts in patients undergoing lower extremity revascularization seems to be significantly reduced after epidural anesthesia. Amputation and the incidence of revision for graft occlusion as clinical markers for graft failure are reduced (3,5,13). The effects on coagulation described above probably reflect only one possible mechanism by which epidurally administered LA may modulate clinical outcome.

Tuman et al. (5) described a sustained increase in blood flow to the legs in patients with occlusive atherosclerotic disease because of extended sympathetic block with the postoperative administration of epidural LA. Sympathetic block caused by epidural anesthesia increased blood flow in the legs of patients with occlusive atherosclerotic disease in a study by Haljamae et al. (65). These findings are supported by a retrospective study by Scott et al. (66), who reported a smaller rate of microvascular complications in free skin flaps to the lower extremity. They suggested that pain relief and vasodilation (sympathicolysis) with epidural LA improve conduit blood flow to the free flap, as well as the microvascular flow distribution within the flap. Another group (67) has discussed possible prevention of postoperative vasospasm by LA.

One approach to elucidating the direct effects of LA in the microvascular bed is intravital microscopy. After topical application of lidocaine, thrombus formation was reduced and microcirculatory blood flow was restored after laser-induced microvascular injury in a hamster cheek pouch model. A reduction of adhesion was observed both between all blood cells and between these cell clusters and the vessel wall (68). The mechanisms are not yet elucidated; however, it seems that the route of application has a role. Thoracic epidural anesthesia increases gut mucosal blood flow in rats by increasing blood cell velocity, and reduces adverse intermittent flow in the villous microcirculation, despite a reduction in perfusion pressure caused by sympathicolysis (69). Other investigations suggest a systemic effect of the LA on PGE2 (23), TXA2 (24), lysophosphatidic acid receptor (25), and other G protein-coupled receptors (28), which are of major importance for regulating regional blood flow. This might be a contributory mechanism to neuraxial blockade and sympathicolysis caused by thoracic epidural anesthesia.


   Conclusion
Top
 Introduction
 Stress Response
 Coagulation Factors and...
 Platelet Aggregation
 Inflammatory Response
 Microcirculation
 Conclusion
References
 
Evidence shows that the prolonged use of epidurally administered LAs affect perioperative coagulation and microcirculation, and have the potential to improve the perioperative outcome (13,70). However, there is evidence that the systemic effects of LAs resorbed from the epidural space contribute to some of these actions. The mechanisms of the direct effects of LA remain unclear, but they affect the modulation of coagulation, fibrinolysis, inflammation, and platelet aggregation as well as the microcirculation without increased blood loss or more perioperative infections. Unfortunately, there are few studies dealing with systemically administered LA in general, and in respect to clinical outcome. Therefore, a discrimination between the direct systemic effects of LA and the effects of the neuraxial blockade, for instance, in epidural anesthesia and analgesia cannot be made. In the future, additional control groups in clinical studies, consisting of patients receiving systemically administered LAs, should be included if ethically appropriate.

There is a potential for an improved outcome after surgical procedures that is associated with significant perioperative stress reduction when regional anesthesia is used. The question arises, therefore, whether patients with contraindications to regional anesthesia should receive LAs IV for the surgical procedure. Although studies in this field have been neglected, there is growing evidence that some patients would benefit from systemically administered LAs.


   References
Top
 Introduction
 Stress Response
 Coagulation Factors and...
 Platelet Aggregation
 Inflammatory Response
 Microcirculation
 Conclusion
 References
 

  1. Collins GJ, Barber JA, Zajtchuk R, et al. The effects of operative stress on the coagulation profile. Am J Surgery 1977; 133: 612–6.[Web of Science][Medline]
  2. Donadoni R, Baele G, Devulder J, Rolly G. Coagulation and fibrinolytic parameters in patients undergoing total hip replacement: influence of the anaesthesia technique. Acta Anaesthesiol Scand 1989; 33: 588–92.[Web of Science][Medline]
  3. Christopherson R, Beattie C, Frank SM, et al. Perioperative morbidity in patients randomized to epidural or general anesthesia for lower-extremity vascular surgery: Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology 1993; 79: 422–34.[Web of Science][Medline]
  4. Rosenfeld BA, Beattie C, Christopherson R, et al. The effects of different anesthetic regimes on fibrinolysis and the development of postoperative arterial thrombosis: Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology 1993; 79: 435–43.[Web of Science][Medline]
  5. Tuman KJ, McCarthy RJ, March RJ, et al. Effects of epidural anesthesia and analgesia on coagulation and outcome after major vascular surgery. Anesth Analg 1991; 73: 696–704.[Abstract/Free Full Text]
  6. Breslow MJ, Parker SD, Frank SM, et al. Determinants of catecholamine and cortisol responses to lower-extremity revascularization: The PIRAT Study Group. Anesthesiology 1993; 79: 1202–9.[Web of Science][Medline]
  7. Andersson TR, Berner NS, Larsen ML, et al. Plasma heparin cofactor II, protein C and antithrombin in elective surgery. Acta Chir Scand 1987; 153: 291–6.[Web of Science][Medline]
  8. O’Brien JR, Tulevski VG, Etherington M, et al. Platelet function studies before and after operation and the effect of postoperative thrombosis. J Lab Clin Med 1974; 83: 342–54.[Web of Science][Medline]
  9. Ygge J. Changes in blood coagulation and fibrinolysis during the post-operative period. Am J Surg 1970; 119: 225–32.[Web of Science][Medline]
  10. Opal SM. Phylogenetic and functional relationships between coagulation and the innate immune response. Crit Care Med 2000; 28: S77–80.[Web of Science][Medline]
  11. Ross RA, Clarke JE, Armitage EN. Postoperative pain prevention by continuous epidural infusion. Anaesthesia 1980; 35: 663–8.[Web of Science][Medline]
  12. Dahl JB, Kehlet H. Non-steroidal anti-inflammatory drugs: rationale for use in severe postoperative pain. Br J Anaesth 1991; 66: 703–12.[Free Full Text]
  13. Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 2000; 321: 1493.[Abstract/Free Full Text]
  14. Modig J, Borg T, Bagge L, Saldeen T. Role of extradural and general anaesthesia in fibrinolysis and coagulation after total hip replacement. Br J Anaesth 1983; 55: 625–9.[Abstract/Free Full Text]
  15. Modig J, Maripuu E, Sahlstedt B. Thromboembolism following total hip replacement: a prospective investigation of 94 patients with emphasis on the efficacy of lumbar epidural anesthesia in prophylaxis. Reg Anesth 1986; 11: 72–9.
  16. Yeager MP, Glass DD, Neff RK, Brinck-Johnsen T. Epidural anesthesia and analgesia in high-risk surgical patients. Anesthesiology 1987; 66: 729–36.[Web of Science][Medline]
  17. Engquist A, Brandt MR, Fernandes A, Kehlet H. The blocking effects of epidural analgesia on the adrenocortical and hyperglycemic responses to surgery. Acta Anaesthesiol Scand 1977; 21: 330–5.[Web of Science][Medline]
  18. Kehlet H. The stress response to surgery: release mechanisms and the modifying effect of pain relief. Acta Chir Scand Suppl 1983; 550: 22–8.
  19. Rutberg H, Hakanson E, Anderberg B, et al. Effects of the extradural administration of morphine or bupivacaine on the endocrine response to upper abdominal surgery. Br J Anaesth 1984; 56: 233–8.[Abstract/Free Full Text]
  20. Nielsen TH, Nielsen HK, Husted SE, et al. Stress response and platelet function in minor surgery during epidural bupivacaine and general anaesthesia: effect of epidural morphine addition. Eur J Anaesthesiol 1989; 6: 409–17.[Web of Science][Medline]
  21. Ardlie NG, Cameron HA, Garret J. Platelet activation by circulating levels of hormones: a possible link in coronary heart disease. Thromb Res 1984; 36: 315–22.[Web of Science][Medline]
  22. Uza G, Crisnic I. Effects of angiotensin II upon platelet adhesiveness and the thromboelastogram in patients with essential hypertension. Pathol Eur 1975; 10: 327–32.[Web of Science][Medline]
  23. Hoenemann CW, Heyse T, Moellhoff T, et al. The inhibitory effect of bupivacaine on prostaglandin E2(EP1) receptor functioning. Anesth Analg 2001; 93: 628–34.[Abstract/Free Full Text]
  24. Honemann CW, Lo B, Erera JS, et al. Local anesthetic effects on TXA2 receptor mediated platelet aggregation using quenched flow aggregometry. Adv Exp Med Biol 1999; 469: 269–76.[Web of Science][Medline]
  25. Sullivan LM, Honemann CW, Arledge JA, Durieux ME. Synergistic inhibition of lysophosphatidic acid signaling by charged and uncharged local anesthetics. Anesth Analg 1999; 88: 1117–24.[Abstract/Free Full Text]
  26. Hollmann MW, Wieczorek KS, Smart M, Durieux ME. Epidural anesthesia prevents hypercoagulation in patients undergoing major orthopedic surgery. Reg Anesth Pain Med 2001; 26: 215–22.[Web of Science][Medline]
  27. Kohrs R, Hoenemann CW, Feirer N, Durieux ME. Bupivacaine inhibits whole blood coagulation in vitro. Reg Anesth Pain Med 1999; 24: 326–30.[Web of Science][Medline]
  28. Hollmann MW, Wieczorek KS, Berger A, Durieux ME. Local anesthetic inhibition of G protein-coupled receptor signaling by interference with G{alpha}(q) protein function. Mol Pharmacol 2001; 59: 294–301.[Abstract/Free Full Text]
  29. McDaniel MD, Pearce WH, Yao JST, et al. Sequential changes in coagulation and platelet function following femorotibial bypass. J Vasc Surg 1984; 1: 261–8.[Web of Science][Medline]
  30. Bredbacka S, Blomback M, Hagnevik K, et al. Pre- and postoperative changes in coagulation and fibrinolytic variables during abdominal hysterectomy under epidural or general anaesthesia. Acta Anaesthesiol Scand 1986; 30: 204–10.[Web of Science][Medline]
  31. Henny CP, Odoom JA, Ten Cate JW, et al. Effects of extradural bupivacaine on the haemostatic system. Br J Anaesth 1986; 58: 301–5.[Abstract/Free Full Text]
  32. Odoom JA, Dokter PW, Sturk A, et al. The influence of epidural analgesia on platelet function and correlation with plasma bupivacaine concentrations. Eur J Anaesthesiol 1988; 5: 305–12.[Web of Science][Medline]
  33. Hollmann MW, Wieczorek KS, Smart M, Durieux ME. Epidural anesthesia prevents hypercoagulation in patients undergoing major orthopedic surgery. Reg Anesth Pain Med 2001; 26: 215–22.
  34. Borg T, Modig J. Potential anti-thrombotic effects of local anaesthetics due to their inhibition of platelet aggregation. Acta Anaesthesiol Scand 1985; 29: 739–42.[Web of Science][Medline]
  35. Weksler BB, Gillick M, Pink J. Effect of propanolol on platelet function. Blood 1977; 49: 185–96.[Abstract/Free Full Text]
  36. Langslet A. Membrane stabilization and cardiac effects of D,L-propanolol, D-propanolol and chlorpromazine. Eur J Pharmacol 1970; 13: 6–14.[Web of Science][Medline]
  37. Cooke ED, Bowcock SA, Lloyd MJ, Pilcher MF. Intravenous lignocaine in prevention of deep venous thrombosis after elective hip surgery. Lancet 1977; 15: 797–9.
  38. Detwiler TC, Charo IF, Feinmann RD. Evidence that calcium regulates platelet function. Thromb Haemost 1978; 40: 207–11.[Web of Science][Medline]
  39. Feinstein MB, Fiekers J, Fraser C. An analysis of the mechanism of local anesthetic inhibition of platelet aggregation and secretion. J Pharmacol Exp Ther 1976; 197: 215–28.[Abstract/Free Full Text]
  40. Garcia-Martin E, Gutierrez-Merino C. Local anesthetics inhibit the Ca2+, Mg2+-ATPase activity of rat brain synaptosomes. J Neurochem 1986; 47: 668–72.[Web of Science][Medline]
  41. Blaise GA, Parent M, Laurin S, et al. Platelet-induced vasomotion of isolated canine coronary artery in the presence of halothane and isoflurane. J Cardiothorac Vasc Anesth 1994; 8: 175–81.[Medline]
  42. Yamamoto Y, Kamiya K, Terao S. Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interaction. J Med Chem 1993; 36: 820–5.[Web of Science][Medline]
  43. Teoh KH, Fremes SE, Weisel RD, et al. Cardiac release of prostacyclin and thromboxane A2 during coronary revascularization. J Thorac Cardiovasc Surg 1987; 93: 120–6.[Abstract]
  44. Vesterqvist O, Schott U, Berseus O, et al. In vivo production of thromboxane and prostacyclin in patients following total hip arthroplasty. Scand J Clin Lab Invest 1987; 48: 233–9.
  45. Friedhoff LT, Kim E, Priddle M, Sonenberg M. The effect of altered transmembrane ion gradients on membrane potential and aggregation of human platelets in blood plasma. Biochem Biophys Res Commun 1981; 102: 832–7.[Web of Science][Medline]
  46. Shattil SJ, Cooper RA. Membrane viscosity and human platelet function. Biochemistry 1976; 15: 4832–7.[Medline]
  47. Sandler WC, Le Breton GC, Feinberg H. Movement of sodium into human platelets. Biochem Biophys Acta 1980; 600: 448–55.[Medline]
  48. Kawasaki T, Dewerchin M, Lijnen HR, et al. Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development. Circ Res 2001; 88: 159–66.[Abstract/Free Full Text]
  49. Palabrica T, Lobb R, Furie BC, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992; 359: 848–51.[Medline]
  50. Theilmeier G, Lenaerts T, Remacle C, et al. Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stress. Blood 1999; 94: 2725–34.[Abstract/Free Full Text]
  51. Enkhbaatar P, Okajima K, Murakami K, et al. Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation. Am J Respir Crit Care Med 2000; 162: 1752–9.[Abstract/Free Full Text]
  52. Heymans S, Luttun A, Nuyens D, et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999; 5: 1135–42.[Web of Science][Medline]
  53. MacGregor RR, Thorner RE, Wright DM. Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites. Blood 1980; 56: 203–9.[Free Full Text]
  54. Martinsson T, Oda T, Fernvik E, et al. Ropivacaine inhibits leukocyte rolling, adhesion and CD11b/CD18 expression. J Pharmacol Exp Ther 1997; 283: 59–65.[Abstract/Free Full Text]
  55. Fischer LG, Bremer M, Coleman EJ, et al. Local anesthetics attenuate lysophosphatidic acid-induced priming in human neutrophils. Anesth Analg 2001; 92: 1041–7.[Abstract/Free Full Text]
  56. Peck SL, Johnston RBJ, Horwitz LD. Reduced neutrophil superoxide anion release after prolonged infusions of lidocaine. J Pharmacol Exp Ther 1985; 235: 418–22.[Abstract/Free Full Text]
  57. Cullen BF, Haschke RH. Local anesthetic inhibition of phagocytosis and metabolism of human leukocytes. Anesthesiology 1974; 40: 142–6.[Web of Science][Medline]
  58. Kanbara T, Tomoda MK, Sato EF, et al. Lidocaine inhibits priming and protein tyrosine phosphorylation of human peripheral neutrophils. Biochem Pharmacol 1993; 45: 1593–8.[Web of Science][Medline]
  59. Dickstein R, Kiremidjian-Schumacher L, Stotzky G. Effects of lidocaine on the function of immunocompetent cells. I. In vitro exposure of mouse spleen lymphocytes and peritoneal macrophages. Immunopharmacology 1985; 9: 117–25.[Web of Science][Medline]
  60. Nietgen GW, Chan CK, Durieux ME. Inhibition of lysophosphatidate signaling by lidocaine and bupivacaine. Anesthesiology 1997; 86: 1112–9.[Web of Science][Medline]
  61. Honemann CW, Arledge JA, Podranski T, et al. Volatile and local anesthetics interfere with thromboxane A2 receptors recombinantly expressed in Xenopus oocytes. Adv Exp Med Biol 1999; 469: 277–83.[Web of Science][Medline]
  62. Butterworth J, James RL, Grimes J. Structure-affinity relationships and stereospecificity of several homolog local anesthetics for the beta2-adrenergic receptor. Anesth Analg 1997; 85: 336–42.[Abstract]
  63. Vladimirov M, Nau C, Mok WM, Strichartz G. Potency of bupivacaine stereoisomers tested in vitro and in vivo: biochemical, electrophysiological, and neurobehavioral studies. Anesthesiology 2000; 93: 744–55.[Web of Science][Medline]
  64. Zhou W, Arrabit C, Choe S, Slesinger PA. Mechanisms underlying bupivacaine inhibition of G protein-gated inwardly rectifying K+ channels. Proc Natl Acad Sci USA 2001; 98: 6482–7.[Abstract/Free Full Text]
  65. Haljamae H, Frid H, Holm J, Akerstrom G. Epidural versus general anesthesia and leg blood flow in patients with occlusive atherosclerotic disease. Eur J Vasc Surg 1988; 2: 395–400.[Medline]
  66. Scott GR, Rothkopf DM, Walton RL. Efficacy of epidural anesthesia in free flaps to the lower extremity. Plast Reconstr Surg 1993; 91: 673–7.[Web of Science][Medline]
  67. Phelps DB, Rutherford RB, Boswick JA. Control of vasospasm following trauma and microvascular surgery. J Hand Surg 1979; 4: 109–17.
  68. Luostarinen V, Evers H, Lyytikainen MT, et al. Antithrombotic effects of lidocaine and related compounds on laser-induced microvascular injury. Acta Anaesthesiol Scand 1981; 25: 9–11.[Web of Science][Medline]
  69. Sielenkamper AW, Eicker K, Van Aken H. Thoracic epidural anesthesia increases mucosal perfusion in ileum in rats. Anesthesiology 2000; 93: 844–51.[Web of Science][Medline]
  70. Brodner G, Van Aken H, Hertle L, et al. Multimodal perioperative management—combining thoracic epidural analgesia, forced mobilization, and oral nutrition—reduces hormonal and metabolic stress and improves convalescence after major urologic surgery. Anesth Analg 2001; 92: 1594–600.[Abstract/Free Full Text]
Accepted for publication February 5, 2002.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
S. S. Liu and C. L. Wu
Effect of Postoperative Analgesia on Major Postoperative Complications: A Systematic Update of the Evidence
Anesth. Analg., March 1, 2007; 104(3): 689 - 702.
[Abstract] [Full Text] [PDF]

Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
J. N. Ghansah and J. T. Murphy
Complications of Major Aortic and Lower Extremity Vascular Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2004; 8(4): 335 - 361.
[Abstract] [PDF]

Home page
 Anesth. Analg.Home page
K. Hahnenkamp, J. Nollet, D. Strumper, T. Halene, P. Rathman, E. Mortier, H. Van Aken, J. Knapp, M. E. Durieux, and C. W. Hoenemann
Bupivacaine Inhibits Thromboxane A2-Induced Vasoconstriction in Rat Thoracic Aorta
Anesth. Analg., July 1, 2004; 99(1): 97 - 102.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
D. Harmon, W. Lan, K. Hahnenkamp, and C. W. Hoenemann
Effects of Systemic Local Anesthetics on Perioperative Ischemia Reperfusion May Be Beneficial * Response
Anesth. Analg., February 1, 2003; 96(2): 629 - 629.
[Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hahnenkamp, K.
Right arrow Articles by Hoenemann, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hahnenkamp, K.
Right arrow Articles by Hoenemann, C. W.
Related Collections
Right arrow Cardiovascular
Right arrow Trauma
Right arrow Pharmacology

Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2002 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press